Amisulpride
Product Specifications
CAS Number
71675-85-9
Target
Dopamine Receptor|||5-HT Receptor
Related Pathways
Neuroscience|||GPCR/G Protein
Purity
0.9999
Bioactivity
Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban) . Amisulpride is a selective dopamine antagonist.
Smiles
C(NCC1N(CC)CCC1)(=O)C2=C(OC)C=C(N)C(S(CC)(=O)=O)=C2
Molecular Formula
C17H27N3O4S
Molecular Weight
369.48
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS639797-01 0.1 mg
Tissue, Membrane Protein, Human Adult Normal, Brain, Hippocampus
Ask
View Details 
MBS639797-02 5x 0.1 mg
Tissue, Membrane Protein, Human Adult Normal, Brain, Hippocampus
Ask
View Details MBS6379427-01 0.1 mL
GARS (Glycyl-tRNA Synthetase, Glycyl-tRNA Synthetase, Glycine-tRNA Ligase, GlyRS) (PE)
Ask
View Details MBS6379427-02 5x 0.1 mL
GARS (Glycyl-tRNA Synthetase, Glycyl-tRNA Synthetase, Glycine-tRNA Ligase, GlyRS) (PE)
Ask
View Details 